Ftse Mib
35.392,46
0,07%
DAX
18.738,81
-0,72%
S&P 500
5.316,34
0,15%
NASDAQ
16.776,16
0,20%
Bitcoin
65.786,26
-0,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Stoke Therapeutics Inc (STOK) Stoke Therapeutics Inc (STOK) Notizie

Stoke Therapeutics Inc

STOK
14,195
0,065 (0,46%)
Ultimo aggiornamento: 17:47:13
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202413:05EDGAR2Form 8-K - Current report
06/5/202413:00BWStoke Therapeutics Reports First Quarter Financial Results..
29/4/202414:00BWStoke Therapeutics Appoints Thomas Leggett as Chief..
17/4/202414:00BWStoke Therapeutics Appoints Jason Hoitt as Chief Commercial..
04/4/202422:30BWStoke Therapeutics to Present at the 23rd Annual Needham..
28/3/202404:40BWStoke Therapeutics Announces Pricing of Upsized $125 Million..
26/3/202421:07BWStoke Therapeutics Announces Proposed Public Offering
25/3/202421:01BWStoke Therapeutics Announces Landmark New Data That Support..
05/3/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:28EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202416:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
17/1/202422:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
08/1/202414:09EDGAR2Form 8-K - Current report
08/1/202414:00BWStoke Therapeutics Highlights Strategic Priorities and..
04/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30BWStoke Therapeutics to Present at the 42nd Annual J.P. Morgan..
02/1/202422:29EDGAR2Form 144 - Report of proposed sale of securities
14/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:08EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
01/12/202315:04EDGAR2Form 8-K - Current report
01/12/202315:00BWStoke Therapeutics Presents Data From Multiple Studies of..
21/11/202314:00BWStoke Therapeutics to Present Data from the Company’s Dravet..
17/11/202322:37EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
09/11/202322:28EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:05EDGAR2Form 8-K - Current report
07/11/202313:00BWStoke Therapeutics Reports Third Quarter Financial Results..
06/11/202322:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202314:01EDGAR2Form SC TO-I - Tender offer statement by Issuer
26/10/202323:00EDGAR2Form 8-K - Current report
17/10/202322:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
28/9/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
21/9/202314:00BWStoke Therapeutics to Participate in the 2023 Cantor Global..
20/9/202322:37EDGAR2Form 8-K - Current report
20/9/202322:30BWStoke Therapeutics Appoints Ian Smith to its Board of..
18/9/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
05/9/202313:00BWStoke Therapeutics Presents Data Related to the Ongoing..
07/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202313:05EDGAR2Form 8-K - Current report
07/8/202313:00BWStoke Therapeutics Reports Second Quarter Financial Results..
02/8/202314:00BWStoke Therapeutics to Present at the Canaccord Genuity 43rd..
25/7/202313:05EDGAR2Form 8-K - Current report
Apertura: 14,15 Min: 13,91 Max: 14,39
Chiusura: 14,13

La tua Cronologia

NASDAQ
STOK
Stoke Therapeutics
BIT
P20ME8
NLBNPIT20ME8 20240528 85
NYSE
CLAA
Colonnade Acquisition Co...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network